| Followers | 36 |
| Posts | 8284 |
| Boards Moderated | 0 |
| Alias Born | 04/14/2011 |
Tuesday, May 05, 2020 7:49:10 AM
New Composition of Matter Patent Allowance Extends Protection for Berotralstat in U.S. Market by Four Years to 2039 was announced at 7am this morning!
Recent BCRX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 05:06:28 PM
- BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026 • GlobeNewswire Inc. • 05/13/2026 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 08:06:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:08:17 AM
- BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/05/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 11:06:53 AM
- BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema • GlobeNewswire Inc. • 05/04/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 09:02:16 PM
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 04/28/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 08:10:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 08:02:30 PM
- BioCryst to Report First Quarter 2026 Financial Results on May 6 • GlobeNewswire Inc. • 04/15/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 08:24:44 PM
- BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer • GlobeNewswire Inc. • 04/06/2026 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/03/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 08:02:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/20/2026 03:36:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:11:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:17:15 PM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:36:58 PM
